An observational study in Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children, sponsored by Merna Fayez (Faiz) Shenoda. Not yet recruiting at 1 site in Egypt. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-08-21.
Sponsored by Merna Fayez (Faiz) Shenoda · Observational
This is a study at sohag university hospital aim to demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children.
This study is a case control aims to :
352 studies on the registry are indexed under Celiac Disease; 77 are open to participants now.
This study's planned enrollment of 30 is below the median of 185 across 134 observational studies indexed under Celiac Disease.
Browse Celiac Disease studies →This is the only study on the registry with Merna Fayez (Faiz) Shenoda as lead sponsor.
Counted across the registry records on this site, refreshed daily.
All children who confirmed diagnosed as celiac disease who visit sohag University Hospital at time of study under 18 years old and don't have any associated disease cross matched with same number of healthy children at the same age and not have any other problems at the duration of study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
cardiac disease.
children from birth to 18 years old diagnosed with celiac disease visit sohag university hospital
Other: No intervention (observational study)
the study don't need intervention.
Assessment of Tp-e Interval
Assessment of Tp-e Interval in children diagnosed with celiac disease and compare it with healthy children
Time frame: 1 year
Assessment of QT dispersion
Assessment of QT dispersion in children diagnosed with celiac disease and compare it with healthy children
Time frame: 1 year
Plan to share: No — individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital
Start is estimated for Aug 2026; primary completion for Jun 2027, 10 months later.
Of 48 observational studies under Celiac Disease, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 83. This study's planned 10 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.